Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
The Fluorescence In Situ Hybridization, Chromosome 17p Deletion (TP53) (product code PNK) is a Class 3 in vitro diagnostic device using a FISH kit to detect deletion of the TP53 gene in peripheral blood specimens from patients with B-cell chronic lymphocytic leukemia (CLL). Class 3 devices require Premarket Approval (PMA). The assay has no assigned regulation number or formal medical specialty designation and is not an implant or life-sustaining device.
Basic Information
- Product Code
- PNK
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- MG
- Submission Type
- 2
Device Characteristics
Definition
A chromosome 17p deletion (TP53) fluorescence in situ hybridization (FISH) kit is a test to detect deletion of the TP53 gene in peripheral blood specimens from patients with B-cell chronic lymphocytic leukemia (CLL).
FEI Numbers
This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.